Treatment for Bankart Lesions

1
Effectiveness
2
Safety
University of Ottawa/Ottawa Hospital, Ottawa, Canada
Bankart Lesions+2 More
Eligibility
Any Age
All Sexes
Eligible conditions
Bankart Lesions

Study Summary

This study is evaluating whether arthroscopic Bankart repair with and without arthroscopic infraspinatus remplissage is better than arthroscopic Bankart repair alone.

See full description

Eligible Conditions

  • Bankart Lesions
  • Hill Sachs Lesion
  • Other Instability, Shoulder

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 3 secondary outcomes in patients with Bankart Lesions. Measurement will happen over the course of 24 months post-surgery.

24 months post-surgery
American Shoulder and Elbow Society assessment (ASES)
Simple Shoulder Test
Ultrasound imaging
Western Ontario Shoulder Instability (WOSI) score

Trial Safety

Safety Estimate

2 of 3
This is better than 68% of similar trials

Trial Design

2 Treatment Groups

Bankart repair and remplissage

This trial requires 150 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 2 and have already been tested with other people.

Bankart repair and remplissage
Procedure
Bankart repair
Procedure

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 months post-surgery
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 24 months post-surgery for reporting.

Who is running the study

Principal Investigator
P. M.
Peter MacDonald, Department Head, Orthopaedic Surgery
Panam Clinic

Closest Location

University of Ottawa/Ottawa Hospital - Ottawa, Canada

Eligibility Criteria

This trial is for patients born any sex of any age. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
14 years or older
must have anterior shoulder instability and Hill-Sachs defect
must have anterior instability with any engaging Hill Sachs Lesion on CT scan, MRI or ultrasound and no more than 15% glenoid bone loss

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Bankart Lesions by sharing your contact details with the study coordinator.